Sex differences in coronary artery disease
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-02 · 399 (4) · 4701-4706
DOI: 10.1007/s00210-025-04751-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 25.10.2025. Verfasst von Lena Marie Seegers. Beteiligte Einrichtung: Department of Cardiology and Angiology, Frankfurt University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. lena.seegers@unimedizin-ffm.de. Hauptthemen laut MEDLINE: Coronary Artery Disease, Sex Characteristics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johann Wolfgang Goethe-Universität, Frankfurt am Main.
Abstract (Originalsprache)
Myocardial infarction is the leading cause of death worldwide in men and in women. Nevertheless, cardiovascular diseases in women are still understudied, underdiagnosed and undertreated leading to poor outcomes and higher mortality rates. Important sex differences exist in coronary artery disease with a higher symptom burden, delayed presentation and treatment of women in the emergency department and more non-obstructive coronary artery disease on angiogram. Sex hormones influence hemostasis and platelet function, and women suffer more from major bleeding complications after coronary interventions. Moreover, cholesterol levels increase with age particularly in women and sex hormones might play an important role in the development and progression of atherosclerosis with an increasing cardiovascular risk for women after menopause. Women also have other unique sex-specific risk factors such as hypertensive disorders of pregnancy that are contributing to an increased risk of myocardial infarction. Therefore, pharmacological therapies regarding primary or secondary prevention of coronary artery disease need to address sex differences to improve female outcome in the future. This review highlights these differences and specific risk factors in women to consider in pharmacological management of coronary artery disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology and Angiology, Frankfurt University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. lena.seegers@unimedizin-ffm.de.
Förderung
- Johann Wolfgang Goethe-Universität, Frankfurt am Main
Zitieren
APA
Seegers, L. M. (2026). Sex differences in coronary artery disease. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(4), 4701-4706. https://doi.org/10.1007/s00210-025-04751-2
Vancouver
Seegers LM. Sex differences in coronary artery disease. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(4):4701-4706. doi:10.1007/s00210-025-04751-2
BibTeX
@article{Seegers2026,
author = {Seegers, Lena Marie},
title = {Sex differences in coronary artery disease},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {4},
pages = {4701--4706},
doi = {10.1007/s00210-025-04751-2}
}
EUVIMED